RHO and cancer: The modes of action of dominant-negative mutants of RhoA in cancers are not clear, but as there is an inverse relationship between RhoA signaling and Rac1 signaling, at least in some cell types it is possible that inhibition of the Rho-regulated pathway results in increased Rac1 signaling [91].